Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation

Bone Marrow Transplantation

Volumn 33, Issue 7, 2004, Pages 751-758

  Patriarca, Francesca ^a   Skert, C ^a   Sperotto, A ^a   Damiani, D ^a   Cerno, M ^a   Geromin, A ^a   Zaja, F ^a   Stocchi, R ^a   Prosdocimo, S ^a   Fili', C ^a   Fanin, R ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

Chronic graft versus host disease; Cyclosporine; Late onset noninfectious pulmonary complications; Stem cell transplantation; Unrelated donor

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GANCICLOVIR; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THALIDOMIDE; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BRONCHIOLITIS; BRONCHUS BIOPSY; CANCER STAGING; CHRONIC GRANULOCYTIC LEUKEMIA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COUGHING; CYTOMEGALOVIRUS INFECTION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DYSPNEA; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; GUILLAIN BARRE SYNDROME; HEMATOLOGIC DISEASE; HUMAN; HUMAN TISSUE; INCIDENCE; INFECTION; INTERSTITIAL PNEUMONIA; LUNG DISEASE; LUNG FUNCTION TEST; LYMPHOMA; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; MYELOID METAPLASIA; OUTCOMES RESEARCH; PNEUMONIA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REMISSION; RESPIRATORY FAILURE; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; THORAX RADIOGRAPHY; THROMBOCYTOPENIC PURPURA; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BRONCHIOLITIS OBLITERANS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CASE-CONTROL STUDIES; CYCLOSPORINE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PREDNISONE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 9344257738     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704426     Document Type: Article

References (33)

1. Soubani AO, Miller KB, Hassoun, PM. Pulmonary complications of bone marrow transplantation. Chest 1996; 109: 1066-1077.
2. Ralph DD, Springmeyer SC, Sullivan KM et al. Rapidly progressive air-flow-obstruction in marrow transplant recipients. Possible association between obliterative bronchiolitis and chronic graft-versus-host disease. Am Rev Respir Dis 1984; 129: 641-644.
3. Holland HK, Wingard JR, Beschorner WE et al. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-versus-host-disease and low serum IgG. Blood 1988; 72: 621-628.
4. Palmas A, Tefferi A, Myers JL et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 1998; 100: 680-687.
5. Duncker C, Dohr D, von Harsdorf S et al. Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome. Bone Marrow Transplant 2000; 25: 1263-1268.
6. Schultz KR, Green GJ, Wensley D et al. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood 1994; 9: 3212-3220.
7. Wolff D, Reichenberger F, Steiner B et al. Progressive interstitial fibrosis of the lung in sclerodermoid chronic graft-versus-host disease. Bone Marrow Transplant 2002; 29: 357-360.
8. Cutler C, Giri S, Jeyapalan S et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001; 19: 3685-3691.
9. Arai S, Vogelsang GB. Management of graft-versus-host disease. Blood Rev 2000; 14: 190-204.
10. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
11. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus host syndrome in man: a long term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
12. ATS. statement - Snowbird workshop on standardization of spirometry. Am Rev Respir Dis 1979; 119: 831-838.
13. Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989; 111: 368-376.
14. Colby TV, Myers JL. Clinical and histologic spectrum of bronchiolitis obliterans, including bronchiolitis obliterans with organizing pneumonia. Semin Respir Med 1992; 13: 119-133.
15. Sakaida E, Nakaseko C, Hariam A et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantationare significantly associated with chronic graft-versus-host disease and graft-versus-leukaemia effect. Blood 2003; 101: 4236-4242.
16. Curtis DJ, Smale A, Thien F et al. Chronic Airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 169-173.
17. Socie G, Mary JY, Esperou H et al. Health and functional status of adult recipient 1 year after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2001; 113: 194-201.
18. Cerveri I, Fulgoni P, Giorgiani G et al. Lung function abnormalities after bone marrow transplantation in children: has the trend recently changed? Chest 2001; 120: 1900-1906.
19. Gore EM, Lawton CA, Ash RC et al. Pulmonary function changes in long-term survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys 1996; 36: 67-75.
20. Beinert T, Dull T, Wolf K et al. Late pulmonary impairment following allogeneic bone marrow transplantation. Eur J Med Res 1996; 1: 343-348.
21. Crawford SW, Pepe M, Lin D et al. Abnormalities of pulmonary function tests after bone marrow transplantation predict nonrelapse mortality. Am J Respir Crit Care Med 1995; 152: 690-695.
22. Thomas O, Mahe M, Campion L et al. Long-term complications of total body irradiation in adults. Int J Radiat Oncol Biol Phys 2001; 1: 125-131.
23. Lund MB, Kongerund J, Brinch L et al. Decreased lung function in one year survivors of allogeneic bone marrow transplantation conditioned with high-dose busulphan and cyclophosphamide. Eur Respir J 1995; 8: 1269-1274.
24. Sociè G, Clift RA, Blaise D et al. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukaemia: long-term follow-up of 4 randomized studies. Blood 2001; 98: 3569-3574.
25. Poletti V, Salvucci M, Zanchini R et al. The lung as target organ in patients with hematologic disorders. Haematologica 2000; 85: 855-864.
26. Sociè G, Stone JV, Wingard JR et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. N Engl J Med 1999; 341: 14-21.
27. Weiden PL, Flournoy N, Thomas ED et al. Anti-leukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow graft. N Engl J Med 1979; 300: 1068-1073.
28. Sullivan KM, Weiden PL, Storb R et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical sibling as treatment of acute and chronic leukaemia. Blood 1989; 73: 1720-1728.
29. Zaucha JM, Gooley T, Bensinger WI et al. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood 2001; 98: 3221-3227.
30. Mohty M, Bilger K, Jourdan E et al. Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation. Leukemia 2003; 17: 869-875.
31. Lonnqvist B, Aschan J, Ljungman P, Ringden O. Long-term cyclosporine therapy may decrease the risk of chronic graft-versus-host disease. Br J Haematol 1990; 74: 547-548.
32. Bacigalupo A, Majolino A, Van Lint MT et al. Cyclosporine A and chronic graft-versus-host disease. Bone Marrow Transplant 1990; 6: 341-344.
33. Mengarelli A, Iori AP, Romano A et al. One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation. Heamatologica 2003; 88: 315-323.